Wednesday, April 04, 2012

Icahn Lashes Out at Amylin; OvaScience Rakes in $37M - Apr. 4, 2012

Having trouble viewing this email? View in Browser.
BioSpace GenePool
   Wednesday, April 04, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide cost effective coverage for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. The majority of our clinical staff are MDs or PhDs, including oncologists in strategic areas for clinical trials. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
Top Stories 
•  Icahn Lashes Out at Amylin Pharmaceuticals, Inc. (AMLN), Urges Sale of Company More...
•  OvaScience Rakes In $37 Million More...
•  Pfizer Inc. (PFE) Launches Holding-Company Review in Bid to Trim Costs More...
•  Bio-Rad Laboratories, Inc. (BIO) Rises on Bet Family May Seek Sale More...
•  Valeant Pharmaceuticals International (VRX) to Move HQs to Laval, 50 New Jobs to be Created More...
•  Sprout Pharma Takes Root Raising $5 Million for Sexual Dysfunction Drug More...
•  UCB, Inc. (UCBJF.PK) and Amgen (AMGN) Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis More...
•  FDA Finds More Fake Batches of Roche (RHHBY)'s Avastin Cancer Drug in U.S. More...
More Top News
Don't Miss This

Crown Bioscience Inc. leads the field in providing unique translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our multi-disciplinary team of experts, headquartered in the heart of Silicon Valley, with wholly own research facilities in Kanapolis, Beijing (China), and Taicang (China)., provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. CrownBio offers a truly integrated approach to undertaking complete drug discovery programs as well as hit identification, hit-to-lead, and lead optimization projects.

To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330.
Featured Stories
•  Women's Height Linked to Ovarian Cancer, Oxford University Study More...
•  Antibiotics Linked to Retinal Detachment Risk, University of British Columbia Study More...
•  Mice Fed a High-Fat Diet Show Signs of Artery Damage After Only 6 Weeks, University of Virginia Study More...
•  Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby, Federal University of Pelotas Study More...
•  Gladstone Institute Scientists Find Increased ApoE Protein Levels May Promote Alzheimer's Disease More...
•  "Positive Stress" Helps Protect Eye from Glaucoma, Washington University in St. Louis Study More...
•  Bilingual Children Switch Tasks Faster Than Speakers of a Single Language, University of Toronto Study More...
•  Caffeine and Exercise: a Protective Mix Against Skin Cancer, Rutgers Ernest Mario School of Pharmacy Study More...
Tower: Facebook
  More Featured News
Event of the day

2012 Workshop on Protein Aggregation and Immunogenicity
July 9-12, 2012
Early Registration: $695 - $1,395

Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can have serious consequences for patients. Also, immunogenicity can be major stumbling blocks to product development and has even plagued licensed protein therapeutics. To increase understanding of the impact of protein aggregation on immunogenicity, the Workshop will focus on five central areas:

1) clinical aspects of immunogenicity to therapeutic proteins;
2) utility of animal models and in vitro cell assays for assessing immunogenicity of aggregates and particles;
3) causes and control of aggregates and particles in formulations;
4) causes and control of aggregates and particles during processing; and
5) insights and challenges with analytical methods.

Please note: The early registration fee expires May 1, 2012, and includes a buffet for breakfast and lunch each day, opening and closing receptions, and a workshop notebook.

To register and view the schedule of speakers by industry leader's visit our website
Latest Market Insight

Drug Delivery Partnership Strategies

• Learn from interviews with senior drug delivery partnering executives.
• Develop effective partnering strategies based on case studies and analysis of market data.
• Unlock therapeutic value of new biopharmaceutical developments by strategic collaborations for innovative drug delivery technologies.

Click Here for More Information.
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
Top Jobs
Biotech Bay (San Francisco, California)

Gallus Biopharmaceuticals, LLC
Director, Business Development
Establish and grow customer relationships to understand the requirements and champion their needs within Gallus BioPharmaceuticals. Research, identify, investigate and develop new business opportunities (Cell Culture) utilizing a variety of resources within the industry. Capture new business opportunities consistent with established Contract Manufacturing Services goals.

Pharm Country (Wayne, Pennsylvania)

Octagon Research Solutions, Inc.
Recruiting Senior Associate
Reporting directly to the Recruitment Manager within our Human Resources Department, the Senior Associate's primary responsibilities will include the following: The Senior Associate takes the lead in recruitment administration, as well as proactively recruiting for entry to mid-level positions. Source and search for qualified candidates according hiring manager requirements.

BioMidwest (Chicago, Illinois)

Takeda Pharmaceuticals
Manager / Associate Director, Regulatory Strategy
Plans/manage/executes all regulatory activities of all levels of complexity for project of responsibility in development and/or supports regulatory activities for assigned marketed product of responsibility.

Biotech Beach (La Jolla, California)

Pfizer, Inc
Enzymologist/Biochemist, Integrative Biology and Biochemistry
Will make important contributions to our molecular and biochemical understanding of oncogenic signaling pathways through the development of robust, automated enzyme assays and selectivity screens to drive the SAR of our oncology projects.

Genetown (Cambridge, Massachusetts)

Novartis Institutes for BioMedical Research, Inc.
Computational Biologist
Will be working in a dynamic, agile 'dry-lab' research environment committed to the discovery of novel drug targets. You will be providing critical support to colleagues by working closely with other investigators to develop mechanistic hypotheses addressing unmet medical needs.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

Biotech Beach

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Amylin Pharmaceuticals, Inc.
9360 Towne Centre Drive
San Diego, California 92121 U.S.A
Phone: 858-552-2200 Fax: 858-552-2212

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines.

More Company Profiles
Free Resources
FREE Subscription to Nature Methods

Nature Methods is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: